SharpMed, LLC is pleased to announce its 2nd issued United States patent (Issued on August 31, 2021). This 2nd patent relates to our device called the RT3; which is a modern, cost-effective chest tube insertion trainer. There are a number of ways to train on chest tube insertion, but ours seems to be the most cost-effective, ethical, easy, and simple to use. “Simulation is becoming a major part of training for a all medical providers; this device is a game changer and can be used virtually anywhere from a fire department, medical school to hospital” – Chris Salvino, MD, CEO.
